NCT00048295View on ClinicalTrials.gov

Alicaforsen (ISIS 2302) in Patients With Active Crohn's Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2002

Conditions
Crohn's Disease
Interventions
DRUG

Alicaforsen

Trial Locations (15)

Unknown

Kortrijk

Roeselare

Hradic Kralove 2

Olomouc

Prague

Ústí nad Orlicí

Minden

Münster

Torino

Krakow

Szczecin

Warsaw

Wroclaw

Barcelona

Valencia

Sponsors
All Listed Sponsors
lead

Ionis Pharmaceuticals, Inc.

INDUSTRY